Kingworld Medicines Group (01110) Publishes Monthly Return for January 2026
Bulletin Express
Feb 02
Kingworld Medicines Group Limited (Stock Code: 01110) released its monthly return for equity securities, covering the period ended 31 January 2026. The announcement highlights that no changes occurred in the company's authorized share capital of HKD 1,000,000,000, which remains divided into 10,000,000,000 ordinary shares at a par value of HKD 0.1.
The total issued share count at the end of January 2026 was 622,500,000 ordinary shares, unchanged from the previous month. The company confirmed compliance with the 25% minimum public float requirement under relevant Hong Kong listing rules. No warrants, convertible instruments, or new share option issuances were reported during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.